Mounjaro Cost in Connecticut (2026)

Connecticut market notes for Mounjaro (tirzepatide)

For Mounjaro (tirzepatide, diabetes) in Connecticut, Lilly savings-card math applies on commercial diabetes claims; do not assume the same copay if your physician writes tirzepatide for weight loss under a Zepbound NDC. Connecticut (CT) GLP-1 pricing follows national list prices adjusted by local pharmacy competition, employer formulary design, and whether Medicaid or Medicare Advantage dominates the insurance mix. Commercial plans in Connecticut commonly require prior authorization for obesity-indicated brands (Wegovy, Zepbound) while diabetes paths for Ozempic or Mounjaro clear more reliably when medically indicated. Manufacturer savings cards usually exclude government insurance—so Medicare, Medicaid, TRICARE, and VA patients in Connecticut need a separate model than the “$25/month” ads. Before you commit, get a written pharmacy quote for the exact NDC, confirm PA status with your insurer, and compare mail-order specialty copays against a local cash fill.

State cost index modifier: 1.06× · List ~$1,179/mo · Card path typically $25–$106/mo when eligible.